Jump to content

PCFA CEO talks with Prof Michael Hofman and Prof Declan Murphy


Recommended Posts

Thanks for posting this Nev. Interesting first look (for me) at the initial observations from the TheraP trial. I am on standard cabazitaxel treatment, and did not qualify for this trial before they stopped recruiting. I was on Xtandi (enzalutamide) last winter and my PSA was rising, but it was not high enough.

Link to post
Share on other sites
×
×
  • Create New...